Risks and benefits of activated protein C treatment for severe sepsis

scientific article published in September 2002

Risks and benefits of activated protein C treatment for severe sepsis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJMSB020574
P698PubMed publication ID12324562

P50authorPeter Q EichackerQ64827097
P2093author name stringAnthony F Suffredini
Robert S Munford
H Shaw Warren
P433issue13
P407language of work or nameEnglishQ1860
P921main subjectsepsisQ183134
drotrecogin alfaQ412888
P1104number of pages4
P304page(s)1027-1030
P577publication date2002-09-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleRisks and benefits of activated protein C treatment for severe sepsis
P478volume347